<!DOCTYPE html>
<html lang="en"><head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1" name="viewport"/>
<link href="https://cdn-icons-png.flaticon.com/512/4021/4021693.png" rel="icon"/>
<link href="../style.css" rel="stylesheet"/>
<link href="https://fonts.googleapis.com" rel="preconnect"/>
<link crossorigin="" href="https://fonts.gstatic.com" rel="preconnect"/>
<link href="https://fonts.googleapis.com/css2?family=Inter:wght@300;400;500;600&amp;family=Space+Mono:wght@400;700&amp;display=swap" rel="stylesheet"/>
<title>Aripiprazol</title>
</head><body><main class="container"><header class="site-header">
<h1 class="logo"><a href="../index.html">r/anhedonia</a></h1>
<p class="subtitle">Personal Wiki</p>
</header><nav style="margin-bottom: 20px;"><a href="../actions.html">← Back to Personal Wiki</a></nav><section class="card"><h2>Aripiprazol</h2><ul>
<li><img src="https://upload.wikimedia.org/wikipedia/commons/thumb/f/f6/Aripiprazole2D1.svg/1920px-Aripiprazole2D1.svg.png"/></li>
<li>Values are Ki (nM). The smaller the value, the more strongly the drug binds to the site. All data are for human cloned proteins, except 5-HT3 (rat), D4 (human/rat), H3 (guinea pig), and NMDA/PCP (rat). Percentages is for Intrinsic Activity.</li>
<br/>
							TODO START
							<ul>
<li></li>
<li></li>
<li></li>
<br/>
<li></li>
<li></li>
<li></li>
<br/>
<li></li>
<li></li>
<li></li>
<br/>
<li></li>
<li></li>
<li></li>
<li></li>
<br/>
<li></li>
<li></li>
<li></li>
<br/>
<li></li>
<li></li>
<li></li>
<br/>
<li>5-HT1E</li>
<li>3000 - &gt;10000 Ki (nM)</li>
<li>?</li>
<br/>
<li>5-HT2A</li>
<li>6.7 - 39 Ki (nM)</li>
<li>12.7%</li>
<li>Very Weak Partial Agonist or Antagonist</li>
<br/>
<li>5-HT2B</li>
<li>0.25 - 0.47 Ki (nM)</li>
<li>Inverse Agonist</li>
<br/>
<li>5-HT2C</li>
<li>11 - 197 Ki (nM)</li>
<li>82%</li>
<li>Partial Agonist</li>
<br/>
<li>5-HT3</li>
<li>520 - 740 Ki (nM)</li>
<li>?</li>
<br/>
<li>5-HT5A</li>
<li>960 - 1520 Ki (nM)</li>
<li>87%</li>
<li>Near-Full Agonist</li>
<br/>
<li>5-HT6</li>
<li>475 - 665 Ki (nM)</li>
<li>Antagonist</li>
<br/>
<li>5-HT7</li>
<li>6.6 - 14 Ki (nM)</li>
<li>58%</li>
<li>Partial Agonist</li>
<br/>
<li>α1A</li>
<li>26 Ki (nM)</li>
<li>Antagonist</li>
<br/>
<li>α1B</li>
<li>35 Ki (nM)</li>
<li>Antagonist</li>
<br/>
<li>α2A</li>
<li>74.3 Ki (nM)</li>
<li>Antagonist</li>
<br/>
<li>α2B</li>
<li>102 Ki (nM)</li>
<li>?</li>
<br/>
<li>α2C</li>
<li>38 Ki (nM)</li>
<li>Antagonist</li>
<br/>
<li>β1</li>
<li>141 Ki (nM)</li>
<li>Antagonist</li>
<br/>
<li>β2</li>
<li>163 Ki (nM)</li>
<li>Antagonist</li>
<br/>
<li>D1</li>
<li>1290 - 2630 Ki (nM)</li>
<li>Partial Agonist</li>
<br/>
<li>D2S</li>
<li>2.2 - 4.4 Ki (nM)</li>
<li>~60%</li>
<li>Partial Agonist</li>
<br/>
<li>D2L</li>
<li>0.65 - 0.83 Ki (nM)</li>
<li>~50%</li>
<li>Partial Agonist</li>
<br/>
<li>D3</li>
<li>4.3 - 15.1 Ki (nM)</li>
<li>~30%</li>
<li>Partial Agonist</li>
<br/>
<li>D4</li>
<li>417 - 603 Ki (nM)</li>
<li>~30%</li>
<li>Partial Agonist</li>
<br/>
<li>D5</li>
<li>1240 - 3940 Ki (nM)</li>
<li>Antagonist</li>
<br/>
<li>H1</li>
<li>22.5 - 27.7 Ki (nM)</li>
<li>Neutral Antagonist</li>
<br/>
<li>H2</li>
<li>&gt;10000 Ki (nM)</li>
<li>?</li>
<br/>
<li>H3</li>
<li>60 - 388 Ki (nM)</li>
<li>?</li>
<br/>
<li>H4</li>
<li>&gt;10000 Ki (nM)</li>
<li>?</li>
<br/>
<li>M1</li>
<li>6780 Ki (nM)</li>
<li>?</li>
<br/>
<li>M2</li>
<li>3510 Ki (nM)</li>
<li>?</li>
<br/>
<li>M3</li>
<li>4680 Ki (nM)</li>
<li>?</li>
<br/>
<li>M4</li>
<li>1520 Ki (nM)</li>
<li>?</li>
<br/>
<li>M5</li>
<li>2330 Ki (nM)</li>
<li>?</li>
<br/>
<li>GABAA-rho (GABAC)</li>
<li>?</li>
<li>Orthostatic Negative Allosteric Modulator</li>
<br/>
<li>NMDA (PCP1)</li>
<li>1824 Ki (nM)</li>
<li>Uncompetitive Channel Blocker, Antagonist</li>
<br/>
<li>NMDA (PCP2)</li>
<li>1824 Ki (nM)</li>
<li>Uncompetitive Agonist</li>
</ul>
<li><table>
<tr>
<td>SERT</td>
<td>900 - 1260 Ki (nM)</td>
<td>Reuptake Inhibitor</td>
<td></td>
</tr>
<tr>
<td>NET</td>
<td>1340 - 2840 Ki (nM)</td>
<td>Reuptake Inhibitor</td>
<td></td>
</tr>
<tr>
<td>DAT</td>
<td>2560 - 3880 Ki (nM)</td>
<td>Reuptake Inhibitor</td>
<td></td>
</tr>
<tr>
<td>5-HT1A</td>
<td>1.7 - 6.4 Ki (nM)</td>
<td>~68%</td>
<td>Partial Agonist</td>
</tr>
<tr>
<td>5-HT1B</td>
<td>570 - 1090 Ki (nM)</td>
<td>?</td>
<td></td>
</tr>
<tr>
<td>5-HT1D</td>
<td>57 - 79 Ki (nM)</td>
<td>?</td>
<td></td>
</tr>
<tr>
<td>PLACEHOLDER</td>
<td>PLACEHOLDER</td>
<td>PLACEHOLDER</td>
<td></td>
</tr>
<tr>
<td>PLACEHOLDER</td>
<td>PLACEHOLDER</td>
<td>PLACEHOLDER</td>
<td></td>
</tr>
</table></li>
							TODO END
						</ul></section><footer class="site-footer">
<p><a href="../index.html">← Back to Home</a></p>
</footer></main><script src="../js/router.js"></script></body></html>